Abiopharma

🔍 Ferraiolo Caetano Roberto (Executive)

Company: STONERIDGE INC (SRI)

Report Date: 2026-06-15

Detailed Transactions and Holdings:

• Sold 9,000 shares of Common Shares, without par value at $7.55 per share (Direct)
  Date: 2026-06-15 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,996.00 | transaction_form_type: 4
• Holds 42,545 shares of Share Units (Derivative)
  Date: 2026-06-15 | Code: H | shares_owned_after: 42,545.00 | Footnotes: F1, F1, F1

Footnotes:

• F1: Share Units granted to the Reporting Person pursuant to the Company's Long-Term Incentive Plan, payable on a one-for-one basis in Company common shares, 20,801 vesting ratably in equal annual installments of one-third (1/3) on each of March 16, 2027, March 16, 2028, and March 16, 2029, subject to the Reporting Person's continued employment on each applicable vesting date; the remainder for grants made in 2024 and 2025 vest on the applicable third anniversary of the date of grant, subject to the Reporting Person's continued employment on each applicable vesting date.